In the context of melanoma, the loss of USP28-FBW7 complex has been identified as a significant mechanism to BRAFi in the treatment of metastatic melanoma: it causes the accumulation of oncogenic proteins, such as MYC, whose stability is normally regulated by FBW7. The gene discussed is FBXW7; the disease is metastatic melanoma.